Kidney Failure

Time-dependent dysnatremias was significantly associated with mortality among patients with chronic kidney disease, according to data published in Kidney Medicine.

Researchers identified functionally relevant risk factors for pediatric primary focal segmental glomerulosclerosis in African American children, according to data published in the American Journal of Kidney Diseases.

Compared with atorvastatin, rosuvastatin shows higher risks of hematuria, proteinuria and kidney failure in patients with chronic kidney disease.

Among patients with kidney failure who successfully used a permanent access for hemodialysis, the incidence of patency loss was higher with arteriovenous graft use compared with arteriovenous fistula, according to data in Kidney Medicine.

Men and women with persistent microscopic hematuria are at an increased risk for the development of chronic kidney disease, according to data published in the American Journal of Kidney Diseases.

Patients with albuminuric chronic kidney disease without diabetes can experience a significantly increased survival free of kidney failure if treated with the combination of angiotensin receptor blockers and SGLT2 inhibitors.

Among patients with chronic kidney disease, aspirin use did not correlate with reduced risks for CVD, progression to kidney failure or major bleeding, according to data published in Kidney Medicine.

For intermediate- and high-risk patients with chronic kidney disease in primary care clinics, there are “several areas” for care improvement, according to data published in the American Journal of Kidney Diseases.

A high prevalence of patients with chronic kidney disease report decisional conflict about kidney failure treatment, regardless of their risk of kidney failure, according to data published in Kidney Medicine.

Among patients with chronic kidney disease and albuminuria treated with dapagliflozin, researchers did not identify a correlation between acute reduction in eGFR and higher rates of CKD progression.